Bicycle Therapeutics

NASDAQ: BCYC · Real-Time Price · USD
7.45
0.07 (0.95%)
At close: Aug 15, 2025, 3:59 PM
7.98
7.11%
After-hours: Aug 15, 2025, 07:33 PM EDT

Bicycle Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-78.95M -60.99M -51.85M -51.32M -39.86M -26.55M -49.1M -49.9M -42.6M -39.06M -29.98M -28.35M -26.83M -27.56M -18.04M -14.68M -17.91M -16.19M
Depreciation & Amortization
1.7M 1.64M 1.69M 2.17M 1.64M 1.66M 1.65M 1.69M 1.65M 1.56M 1.39M 1.26M 617K 422K 407K 337K 340K 325K
Stock-Based Compensation
9.44M 9.61M 10.33M 9.2M 9.26M 9.28M 7.81M 7.43M 8.19M 9.04M 5.54M 5.37M 5.67M 10.2M 3M 2.69M 2.58M 3.82M
Other Working Capital
637K -21.19M 6.08M -20.91M -7.78M -33.37M -12.29M 83.46M -10.55M -16.46M 2M 2.47M 5.61M -10.33M 8.64M 35.2M -1.78M 236K
Other Non-Cash Items
n/a 36.88K -4.46M 2.82M 126.33K 98.64K 755K 91K 96K 102K 79.93K 88K 136K 135K 121K 124K 130K 93K
Deferred Income Tax
-331K -1.32M -1.03M -3.33M -110K -766.56K -282K 7.27M -1.58M -2.11M -4.97M n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-4.63M -35.68M 35.93M 631.18K -15.77M -54.55M -8.13M 32.39M 68.34M -15.94M -2.36M 15.76M -3.13M -9.59M 4.08M 33.25M 2.5M -1.75M
Operating Cash Flow
-72.79M -86.7M -9.4M -39.83M -44.7M -70.83M -47.29M -1.02M 34.1M -46.41M -30.31M -5.87M -23.53M -26.4M -10.44M 21.72M -12.37M -13.71M
Capital Expenditures
-498K -606.32K -368K -434.87K -420.14K -11.99K -51K -502K -277K -2.1M -1.45M -2.98M -9.8M -4.76M -1.07M -169K -171K -623K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-498K -606.32K -368K -435K -420.14K -11.99K -51K -502K -277K -2.1M -1.45M -2.98M -9.8M -4.76M -1.07M -169K -171K -623K
Debt Repayment
-46K -43K -42K -32.01M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 15M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-18.11 -164 2.25M -2.16M n/a n/a 133.35K 139K 165K 2K 185K 159K 195K 450K 2.27M 3.05M 1.57M 284K
Financial Cash Flow
-45K -41.16K 203K -31.93M 549.78M 1.87M 386K 234.63M 12.29M 2.72M 5.89M 159K 195K 450K 190.66M 40.45M 15.55M 74.06M
Net Cash Flow
-71.52M -86.55M -11.34M -70.5M 504.37M -69.43M -45.66M 232.2M 46.62M -45.34M -22.32M -11.3M -34.6M -31.31M 179.16M 60.79M 2.84M 59.91M
Free Cash Flow
-73.28M -87.31M -9.76M -40.27M -45.12M -70.84M -47.34M -1.53M 33.82M -48.51M -31.76M -8.86M -33.33M -31.16M -11.5M 21.55M -12.54M -14.33M